Peter Arlett
Impact in
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
Papers in
- Toxicology 33
- Pharmacovigilance and Adverse Drug Reactions 33
-
- Health Systems, Economic Evaluations, Quality of Life 15
- Pharmaceutical Economics and Policy 12
- Co-authors
- Xavier Kurz (13 shared papers)Alison Cave (2 shared papers)Qun‐Ying Yue (2 shared papers)Carin Bergquist (1 shared paper)Lindsay M. Henderson (1 shared paper)Barbro Gerdén (1 shared paper)Georgy Genov (6 shared papers)June Raine (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (17 papers)Pharmacoepidemiology and Drug Safety (13 papers)Drug Safety (10 papers)Nature Reviews Drug Discovery (3 papers)International Journal of Technology Assessment in Health Care (1 paper)
- Partner nations
- NetherlandsUnited KingdomIreland
In The Last Decade
Peter Arlett
53 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 131
- Toxicology 461
- Statistics and Probability 237
- Pharmacology 249
- Geriatrics and Gerontology 96
- Economics and Econometrics 607
Countries citing papers authored by Peter Arlett
This map shows the geographic impact of Peter Arlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Arlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Arlett more than expected).
Fields of papers citing papers by Peter Arlett
This network shows the impact of papers produced by Peter Arlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Arlett. The network helps show where Peter Arlett may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Arlett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 238 | |
| 2 | 2019 | 197 | |
| 3 | 2019 | 182 | |
| 4 | 2021 | 121 | |
| 5 | 2020 | 114 | |
| 6 | 2021 | 103 | |
| 7 | 2018 | 90 | |
| 8 | 2017 | 82 | |
| 9 | 2017 | 59 | |
| 10 | 2016 | 54 | |
| 11 | 2015 | 47 | |
| 12 | 2012 | 47 | |
| 13 | 2019 | 44 | |
| 14 | 2014 | 36 | |
| 15 | 2011 | 32 | |
| 16 | 2017 | 30 | |
| 17 | 2012 | 24 | |
| 18 | 2019 | 24 | |
| 19 | 2017 | 24 | |
| 20 | 2014 | 22 |
About Peter Arlett
Peter Arlett is a scholar working on Toxicology, Economics and Econometrics, Immunology, Pharmacology and Pharmacology, having authored 54 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (33 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Biosimilars and Bioanalytical Methods (13 papers), Pharmaceutical Economics and Policy (12 papers), Pharmaceutical industry and healthcare (9 papers), Drug-Induced Adverse Reactions (8 papers), Pharmaceutical studies and practices (7 papers) and Academic integrity and plagiarism (4 papers). The work is most often cited by research in Toxicology (461 citations), Statistics and Probability (237 citations), Pharmacology (249 citations), Geriatrics and Gerontology (96 citations) and Economics and Econometrics (607 citations). Peter Arlett has collaborated with scholars based in Netherlands, United Kingdom and Ireland. Frequent co-authors include Xavier Kurz, Alison Cave, Qun‐Ying Yue, Carin Bergquist, Lindsay M. Henderson, Barbro Gerdén, Georgy Genov, June Raine, Gerald J. Dal Pan and Jim Slattery. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacoepidemiology and Drug Safety, Drug Safety, Nature Reviews Drug Discovery and International Journal of Technology Assessment in Health Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.